'Bac' to the future: Bioengineering lantibiotics for designer purposes

Biochemical Society Transactions

Volumn 40, Issue 6, 2012, Pages 1492-1497

  Molloy, Evelyn M ^a   Ross, R Paul ^b,c   Hill, Colin ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Antimicrobial peptide; Bacteriocin; Bioengineering; Lantibiotic; Mutagenesis; Nisin

Indexed keywords

BACTERIOCIN; LANTIBIOTIC; NISIN; NISIN A; NISIN Z; UNCLASSIFIED DRUG;

BACILLUS SUBTILIS; BIOENGINEERING; CONFERENCE PAPER; DRUG ACTIVITY; DRUG STRUCTURE; LACTOCOCCUS LACTIS; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS THERMOPHILUS; STREPTOCOCCUS UBERIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOCINS; BIOENGINEERING; DRUG DESIGN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NISIN; PROTEIN ENGINEERING; SOLUBILITY;

BACTERIA (MICROORGANISMS);

EID: 84870182562     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120193     Document Type: Conference Paper

References (51)

1. Schnell, N., Entian, K.D., Schneider, U., Gotz, F., Zahner, H., Kellner, R. and Jung, G. (1988) Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333, 276-278
2. Willey, J.M. and van der Donk, W.A. (2007) Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501 (Pubitemid 350058218)
3. Lubelski, J., Rink, R., Khusainov, R., Moll, G.N. and Kuipers, O.P. (2008) Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell. Mol. Life Sci. 65, 455-476 (Pubitemid 351214649)
4. Bierbaum, G. and Sahl, H.G. (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10, 2-18
5. Knerr, P.J. and van der Donk, W.A. (2012) Discovery, biosynthesis, and engineering of lantipeptides. Annu. Rev. Biochem. 81, 479-505
6. Montalban-Lopez, M., Zhou, L., Buivydas, A., van Heel, A.J. and Kuipers, O.P. (2012) Increasing the success rate of lantibiotic drug discovery by synthetic biology. Expert Opin. Drug Discovery 7, 695-709
7. Rogers, L.A. and Whittier, E.O. (1928) Limiting factors in the lactic fermentation. J. Bacteriol. 16, 211-229
8. Galvez, A., Abriouel, H., Lopez, R.L. and Ben Omar, N. (2007) Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 120, 51-70 (Pubitemid 350051481)
9. Van Den Hooven, H.W., Doeland, C.C., Van De Kamp, M., Konings, R.N., Hilbers, C.W. and Van De Ven, F.J. (1996) Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate. Eur. J. Biochem. 235, 382-393 (Pubitemid 26045454)
10. Hsu, S.T., Breukink, E., Tischenko, E., Lutters, M.A., de Kruijff, B., Kaptein, R., Bonvin, A.M. and van Nuland, N.A. (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963-967 (Pubitemid 39315300)
11. Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O.P., Bierbaum, G., de Kruijff, B. and Sahl, H.G. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772-1779 (Pubitemid 32109649)
12. van Heusden, H.E., de Kruijff, B. and Breukink, E. (2002) Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin. Biochemistry 41, 12171-12178
13. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O.P., Sahl, H. and de Kruijff, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361-2364 (Pubitemid 30016902)
14. Hasper, H.E., de Kruijff, B. and Breukink, E. (2004) Assembly and stability of nisin-lipid II pores. Biochemistry 43, 11567-11575 (Pubitemid 39186978)
15. Hasper, H.E., Kramer, N.E., Smith, J.L., Hillman, J.D., Zachariah, C., Kuipers, O.P., de Kruijff, B. and Breukink, E. (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636-1637 (Pubitemid 44414037)
16. Cotter, P.D., Hill, C. and Ross, R.P. (2005) Bacterial lantibiotics: strategies to improve therapeutic potential. Curr. Protein Pept. Sci. 6, 61-75 (Pubitemid 40259802)
17. Piper, C., Cotter, P.D., Ross, R.P. and Hill, C. (2009) Discovery of medically significant lantibiotics. Curr. Drug Discovery Technol. 6, 1-18
18. Montalban-Lopez, M., Sanchez-Hidalgo, M., Valdivia, E., Martinez-Bueno, M. and Maqueda, M. (2011) Are bacteriocins underexploited? Novel applications for old antimicrobials. Curr. Pharm. Biotechnol. 12, 1205-1220
19. van Heel, A.J., Montalban-Lopez, M. and Kuipers, O.P. (2011) Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opin. Drug Metab. Toxicol. 7, 675-680
20. Bartoloni, A., Mantella, A., Goldstein, B.P., Dei, R., Benedetti, M., Sbaragli, S. and Paradisi, F. (2004) In-vitro activity of nisin against clinical isolates of Clostridium difficile. J. Chemother. 16, 119-121 (Pubitemid 38756941)
21. Piper, C., Draper, L.A., Cotter, P.D., Ross, R.P. and Hill, C. (2009) A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J. Antimicrob. Chemother. 64, 546-551
22. Goldstein, B.P., Wei, J., Greenberg, K. and Novick, R. (1998) Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J. Antimicrob. Chemother. 42, 277-278 (Pubitemid 28393607)
23. Severina, E., Severin, A. and Tomasz, A. (1998) Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J. Antimicrob. Chemother. 41, 341-347
24. Sears, P.M., Smith, B.S., Stewart, W.K., Gonzalez, R.N., Rubino, S.D., Gusik, S.A., Kulisek, E.S., Projan, S.J. and Blackburn, P. (1992) Evaluation of a nisin-based germicidal formulation on teat skin of live cows. J. Dairy Sci. 75, 3185-3190
25. Wu, J., Hu, S. and Cao, L. (2007) Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother. 51, 3131-3135 (Pubitemid 350067519)
26. Fernandez, L., Delgado, S., Herrero, H., Maldonado, A. and Rodriguez, J.M. (2008) The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J. Hum. Lact. 24, 311-316
27. Field, D., Hill, C., Cotter, P.D. and Ross, R.P. (2010) The dawning of a 'Golden era' in lantibiotic bioengineering. Mol. Microbiol. 78, 1077-1087
28. Kaletta, C. and Entian, K.D. (1989) Nisin, a peptide antibiotic: cloning and sequencing of the nisA gene and posttranslational processing of its peptide product. J. Bacteriol. 171, 1597-1601 (Pubitemid 19080802)
29. Mulders, J.W., Boerrigter, I.J., Rollema, H.S., Siezen, R.J. and de Vos, W.M. (1991) Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201, 581-584
30. Zendo, T., Fukao, M., Ueda, K., Higuchi, T., Nakayama, J. and Sonomoto, K. (2003) Identification of the lantibiotic nisin Q, a new natural nisin variant produced by Lactococcus lactis 61-14 isolated from a river in Japan. Biosci. Biotechnol. Biochem. 67, 1616-1619 (Pubitemid 39251809)
31. de Kwaadsteniet, M., Ten Doeschate, K. and Dicks, L.M. (2008) Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus). Appl. Environ. Microbiol. 74, 547-549
32. Wirawan, R.E., Klesse, N.A., Jack, R.W. and Tagg, J.R. (2006) Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl. Environ. Microbiol. 72, 1148-1156 (Pubitemid 43271221)
33. Piper, C., Hill, C., Cotter, P.D. and Ross, R.P. (2011) Bioengineering of a nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants nisin F, Q and Z. Microb. Biotechnol. 4, 375-382
34. Morency, H., Mota-Meira, M., LaPointe, G., Lacroix, C. and Lavoie, M.C. (2001) Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic. Can. J. Microbiol. 47, 322-331 (Pubitemid 32745023)
35. de Vos, W.M., Mulders, J.W., Siezen, R.J., Hugenholtz, J. and Kuipers, O.P. (1993) Properties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis. Appl. Environ. Microbiol. 59, 213-218 (Pubitemid 23028393)
36. Rollema, H.S., Kuipers, O.P., Both, P., de Vos, W.M. and Siezen, R.J. (1995) Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol. 61, 2873-2878
37. Kuipers, O.P., Rollema, H.S., Yap, W.M., Boot, H.J., Siezen, R.J. and de Vos, W.M. (1992) Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267, 24340-24346
38. Kuipers, O.P., Rollema, H.S., Bongers, R., van den Bogaard, P., Kosters, H., de Vos, W.M. and Siezen, R.J. (1994), Structure-function relationships of nisin studied by protein engineering. 2nd International Workshop on Lantibiotics, 20-24 November 1994, Arnhem, The Netherlands
39. Rink, R., Wierenga, J., Kuipers, A., Kluskens, L.D., Driessen, A.J., Kuipers, O.P. and Moll, G.N. (2007) Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol. 73, 5809-5816 (Pubitemid 47462992)
40. Yuan, J., Zhang, Z.Z., Chen, X.Z., Yang, W. and Huan, L.D. (2004) Site-directed mutagenesis of the hinge region of nisin Z and properties of nisin Z mutants. Appl. Microbiol. Biotechnol. 64, 806-815 (Pubitemid 38918144)
41. Field, D., Connor, P.M., Cotter, P.D., Hill, C. and Ross, R.P. (2008) The generation of nisin variants with enhanced activity against specific Gram-positive pathogens. Mol. Microbiol. 69, 218-230 (Pubitemid 351832767)
42. Field, D., Quigley, L., O'Connor, P.M., Rea, M.C., Daly, K., Cotter, P.D., Hill, C. and Ross, R.P. (2010) Studies with bioengineered nisin peptides highlight the broad-spectrum potency of nisin V. Microbiol. Biotechnol. 3, 473-486
43. Rouse, S., Field, D., Daly, K.M., O'Connor, P.M., Cotter, P.D., Hill, C. and Ross, R.P. (2012) Bioengineered nisin derivatives with enhanced activity in complex matrices. Microb. Biotechnol. 5, 501-508
44. Oman, T.J. and van der Donk, W.A. (2010) Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat. Chem. Biol. 6, 9-18
45. Majchrzykiewicz, J.A., Lubelski, J., Moll, G.N., Kuipers, A., Bijlsma, J.J., Kuipers, O.P. and Rink, R. (2010) Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence. Antimicrob. Agents Chemother. 54, 1498-1505
46. Moll, G.N., Kuipers, A. and Rink, R. (2010) Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides. Antonie Van Leeuwenhoek 97, 319-333
47. Kluskens, L.D., Kuipers, A., Rink, R., de Boef, E., Fekken, S., Driessen, A.J., Kuipers, O.P. and Moll, G.N. (2005) Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry 44, 12827-12834 (Pubitemid 41377322)
48. Kluskens, L.D., Nelemans, S.A., Rink, R., de Vries, L., Meter-Arkema, A., Wang, Y., Walther, T., Kuipers, A., Moll, G.N. and Haas, M. (2009) Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog. J. Pharmacol. Exp. Ther. 328, 849-854
49. Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S.A., Akanbi, M.H. and Moll, G.N. (2010) To protect peptide pharmaceuticals against peptidases. J. Pharmacol. Toxicol. Methods 61, 210-218
50. Rink, R., Kuipers, A., de Boef, E., Leenhouts, K.J., Driessen, A.J., Moll, G.N. and Kuipers, O.P. (2005) Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry 44, 8873-8882 (Pubitemid 40840453)
51. Field, D., Begley, M., O'Connor, P.M., Daly, K.M., Hugenholtz, F., Cotter, P.D., Hill, C. and Ross, R.P. (2012) Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS ONE 7, e46884